Planet 13 Holdings (PLNH) Non-Current Assets (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Non-Current Assets of $109.1 million for Q1 2026, down 28.26% year-over-year from $152.1 million in Q1 2025, and down 1.85% quarter-over-quarter from $111.1 million in Q4 2025.
Planet 13 Holdings (PLNH) Non-Current Assets (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Non-Current Assets for 6 consecutive years, with $109.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets fell 28.26% year-over-year to $109.1 million; the TTM figure through Mar 2026 stood at $484.9 million (down 28.38% YoY), while the FY2025 annual figure was $111.1 million, down 27.09% from the prior year.
- Non-Current Assets slipped to $109.1 million in Q1 2026 per PLNH's latest filing, from $111.1 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $197.2 million in Q2 2022 and bottomed at $104.4 million in Q4 2023.
- Historically, Non-Current Assets has averaged $151.1 million across 5 years, with a median of $152.4 million in 2024.
- Annual changes were most pronounced in 2024 — Non-Current Assets soared 51.07% — and 2025, when it slumped 38.61%.
- Planet 13 Holdings' Non-Current Assets stood at $163.1 million in 2022, then tumbled by 35.98% to $104.4 million in 2023, then surged by 45.96% to $152.4 million in 2024, then retreated by 27.09% to $111.1 million in 2025, then dropped by 1.85% to $109.1 million in 2026.
- Business Quant data shows PLNH's Non-Current Assets at $109.1 million in Q1 2026, $111.1 million in Q4 2025, and $113.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.96 Bn |
| 10 | Planet 13 Holdings | 52.64 Mn | 36.16 Mn | 12.32 Mn | 106.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106.82 Mn |
| Mar 31, 2026 | 109.08 Mn |
| Dec 31, 2025 | 111.14 Mn |
| Sep 30, 2025 | 113.43 Mn |
| Jun 30, 2025 | 151.21 Mn |
| Mar 31, 2025 | 152.06 Mn |
| Dec 31, 2024 | 152.44 Mn |
| Sep 30, 2024 | 184.78 Mn |
| Jun 30, 2024 | 187.76 Mn |
| Mar 31, 2024 | 104.64 Mn |
| Dec 31, 2023 | 104.44 Mn |
| Sep 30, 2023 | 122.31 Mn |
| Jun 30, 2023 | 163.36 Mn |
| Mar 31, 2023 | 166.01 Mn |
| Dec 31, 2022 | 163.13 Mn |
| Sep 30, 2022 | 194.78 Mn |
| Jun 30, 2022 | 197.15 Mn |
| Mar 31, 2022 | 191.02 Mn |
| Dec 31, 2021 | 135.80 Mn |